A case of malignant insulinoma responsive to somatostatin analogs treatment

BACKGROUND: Insulinoma is a rare tumour representing 1–2% of all pancreatic neoplasms and it is malignant in only 10% of cases. Locoregional invasion or metastases define malignancy, whereas the dimension (> 2 cm), CK19 status, the tumor staging and grading (Ki67 > 2%), and the age of onset (&...

Descripción completa

Detalles Bibliográficos
Autores principales: Caliri, Mariasmeralda, Verdiani, Valentina, Mannucci, Edoardo, Briganti, Vittorio, Landoni, Luca, Esposito, Alessandro, Burato, Giulia, Rotella, Carlo Maria, Mannelli, Massimo, Peri, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307122/
https://www.ncbi.nlm.nih.gov/pubmed/30591061
http://dx.doi.org/10.1186/s12902-018-0325-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307122/
https://www.ncbi.nlm.nih.gov/pubmed/30591061
http://dx.doi.org/10.1186/s12902-018-0325-4

Ejemplares similares